Download video

Dr. Pennell on the Evolution of Targeting HER2 in Lung Cancer

338 views

OncLive

4 years ago

Dr. Pennell on the Evolution of Targeting HER2 in Lung Cancer

Dr. Pennell on the Evolution of Targeting HER2 in Lung Cancer

Dr. Pennell on the Evolution of Targeting HER2 in Lung Cancer
2:22
Dr. Pennell on the Evolution of Targeting HER2 in Lung Cancer
by OncLive
Dr. Pennell on the Evolution of Targeted Treatment in NSCLC
2:12
Dr. Pennell on the Evolution of Targeted Treatment in NSCLC
by OncLive
Strategies to Target HER2 in Lung Cancer
1:45
Strategies to Target HER2 in Lung Cancer
by American Lung Association
Dr. Pennell on Challenges With NGS in Lung Cancer
1:22
Dr. Pennell on Challenges With NGS in Lung Cancer
by OncLive
Challenges to Targeting HER2 in Lung Cancer
1:13
Challenges to Targeting HER2 in Lung Cancer
by American Lung Association
Dr. Pennell on Remaining Challenges in NSCLC
1:41
Dr. Pennell on Remaining Challenges in NSCLC
by OncLive
Dr. Pennell on Considerations for Immediate Treatment in Lung Cancer
2:11
Dr. Pennell on Considerations for Immediate Treatment in Lung Cancer
by OncLive
HER2 Targeted Therapy for Treatment of NSCLC
17:15
HER2 Targeted Therapy for Treatment of NSCLC
by OncLive
New Frontiers in NSCLC: The Promise and Progress of HER2-Directed Therapies
54:17
New Frontiers in NSCLC: The Promise and Progress of HER2-Directed Therapies
by Medscape
Dr. Pennell on Benefits of Liquid Biopsies in Lung Cancer
1:39
Dr. Pennell on Benefits of Liquid Biopsies in Lung Cancer
by OncLive
Nathan Pennell, MD, PhD | Cleveland Clinic Hematology \& Oncology
2:17
Nathan Pennell, MD, PhD | Cleveland Clinic Hematology \& Oncology
by Cleveland Clinic
Dr. Pennell on the Underutilization of Genetic Testing in Lung Cancer
2:26
Dr. Pennell on the Underutilization of Genetic Testing in Lung Cancer
by OncLive
Targeting HER2 Mutations in NSCLC: What Do We Know?
5:49
Targeting HER2 Mutations in NSCLC: What Do We Know?
by OncLive
HER2 Mutation Positive NSCLC
2:54
HER2 Mutation Positive NSCLC
by GRACE - Global Resource for Advancing Cancer Education
Addressing Key Targets in Advanced NSCLC: HER2-, HER3-, and TROP2-Targeted Therapies
58:27
Addressing Key Targets in Advanced NSCLC: HER2-, HER3-, and TROP2-Targeted Therapies
by PeerView Oncology
Therapeutic advances in targeting HER2 alterations in NSCLC \& remaining challenges
2:45
Therapeutic advances in targeting HER2 alterations in NSCLC \& remaining challenges
by VJOncology
What is a HER2 mutation in lung cancer?
1:41
What is a HER2 mutation in lung cancer?
by You and Lung Cancer
Dr. Lopategui on the Evolution of Targeted Therapies in NSCLC
1:18
Dr. Lopategui on the Evolution of Targeted Therapies in NSCLC
by OncLive
Evolution of Targeted Therapy in Advanced NSCLC
4:23
Evolution of Targeted Therapy in Advanced NSCLC
by Targeted Oncology
Dr. Drilon on Targeted Therapies for Patients With ROS1-Rearranged Lung Cancer
1:36
Dr. Drilon on Targeted Therapies for Patients With ROS1-Rearranged Lung Cancer
by OncLive